<DOC>
	<DOCNO>NCT02719808</DOCNO>
	<brief_summary>500 pregnant patient HBeAg-positive HBV-DNA &gt; 106copies /ml pregnant check First Affiliated Hospital Xi'an Jiaotong University enrol study . There five group observe . Four group take tenofovir prevent intrauterine infection pregnancy . One group take anti-HBV virus treatments.The clinical value effectiveness tenofovir block HBV intrauterine infection evaluate ; The HBV-DNA infection status placenta tissue check quantitative Polymerase Chain Reaction ( PCR ) ass change HBV-DNA placenta treat tenofovir explore mechanism tenofovir block HBV intrauterine infection . The safety Tenofovir assess well .</brief_summary>
	<brief_title>Study Antiretroviral Therapy Prevent HBV Intrauterine Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>pregnancy patient HBeAgpositive HBVDNA &gt; 106copies /ml pregnancy patient HBeAgnegative HBVDNAï¼œ106copies /ml</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Vertical infection transmission</keyword>
	<keyword>Tenofovir</keyword>
</DOC>